Global Synthetic Biology Market is Estimated to Reach $15 Billion by 2025
Global Synthetic Biology Market report published by Accurize Market Research forecast that the global market is expected to reach $15 billion by 2025; growing at a CAGR of 26% from 2017 to 2025. By geography, The Asia Pacific and North America are expected to grow at a CAGR of XX% and XX%, respectively, during the forecast period.
Advancements in DNA sequencing and synthesizing technologies, emerging and spreading synthetic biology techniques for various applications to drive the global market
Advancements in DNA sequencing and synthesizing technologies, emerging and spreading synthetic biology techniques for various applications drives the growth of the global synthetic biology market. Moreover, Synthetic biology has an array of applications in the fields of medicine, agriculture, nanotechnology, and industrial biotechnology and technological innovations also might provide growth opportunities.
The global synthetic biology market is split into technology, application, industry, and geography. By technology, the market is bifurcated into enabling technologies and biologic components and integrated systems technologies. Application is segmented into enabling technologies and biologic components and integrated systems technologies. Industries categorized into an industrial biotechnology value chain, industry structural forces, and others.
North America, Europe, Asia-Pacific and Rest of the world (RoW) are the geographical segments of the market.
Top players in the market
Major companies operating in the market include Thermo Fisher, Novozymes, Merck KGaA, Intrexon, and Agilent Technologies, Amyris, GenScript, Ginkgo Bioworks, Integrated DNA Technologies, New England Biolabs, Synthetic Genomics, and Twist Bioscience among others.